Press Release: Efferent Labs® Amplifies Biotech Leadership with Strategic Patent Portfolio Expansion
CHARLESTON, SC – Efferent Labs®, a vanguard in biotechnological innovation, today announced a
Related Posts
Third Trademark Issued
(BUFFALO, NY) Apr. 1, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
Efferent Labs Issued 6th Patent
(BUFFALO, NY) Feb. 15, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in
About Us
Efferent Labs offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.
Let’s Socialize
Popular Post